Search results for: Health Care Systems
Filter search results
Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help? A Summary of a Symposium held at HTAi Rome 2017
31 October 2017
…new antibiotics relating to their impact on public health by preventing AMR growth. HTA focuses on health gain to the treated patient. Six types of benefit that are traditionally not included…
OHE at HESG Winter 2018
4 January 2018
A summary of OHE’s activity at the 2018 winter HESG meeting, City, University of London, 10-12th January. OHE team members will play an active role in the forthcoming Health Economists’…
Seminar Briefing: NHS Agency Staffing and the Impact of Recent Interventions
24 January 2018
…long lead time for training health care staff means that there can sometimes be a shortfall in available staff. This has made recruitment agencies and individual locum staff important suppliers…
Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe? 24th Annual Lecture Publication
19 March 2018
Download OHE’s 24th Annual Lecture publication: Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe? In June 2017, Professor Anne Case and Professor Sir…
Professor Graham Cookson Appointed OHE Director Designate
24 April 2018
…of Economic & Public Policy and Head of the Department of Health Care Management & Policy at University of Surrey. There he won major health research grants from the EU…
OHE’s In-house Publications Are Now Indexed by RePEc
8 May 2018
OHE is on RePEc: find publications from the Office of Health Economics in Research Papers in Economics. For many years, we’ve been publishing our work – free to read – on…
Should Drug Prices Differ by Indication? The Debate on Indication-based Pricing
11 May 2018
…that the price of a medicine should be linked in some way to the value it generates for patients and the health system is generally accepted. Yet, how can this…
A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List
19 May 2018
…reviews “Estimated costs of production and potential prices of medicines for the World Health Organization Essential Medicines List” (Hill et al., 2018) in which the authors argue for “greater transparency…
Incentives, Competition, and Pharmaceutical Innovation in Europe: The Case of Direct Acting Antivirals for Hepatitis C
26 July 2018
…impact of (i) incentives for R&D based on providing intellectual property (IP) rights protection; (ii) market competition; and (iii) other factors, including healthcare policies, on access to DAAs in Europe. …